Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to …

CMP e Silva de Azevedo, O Bruna-Romero… - European journal of …, 2014 - Springer
Chromoblastomycosis (CBM) is a chronic, suppurative, granulomatous mycosis of the skin
and subcutaneous tissues. The aim of this study was to evaluate the association between …

Humoral immune response in chromoblastomycosis during and after therapy

P Esterre, M Jahevitra… - Clinical Diagnostic …, 2000 - Am Soc Microbiol
ABSTRACT A longitudinal study was carried out in Madagascar, the most important focus of
chromoblastomycosis (P. Esterre, A. Andriantsimahavandy, E. Ramarcel, and JL Pecarrere …

The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease

S Corrêa Garcia Pires d'Ávila, C Pagliari… - Mycopathologia, 2003 - Springer
Chromoblastomycosis is a fungal infection caused by dematiaceous fungi inducing skin
lesions of difficult treatment and of frequent recurrence. The objective of the present …

Immunoprecipitation techniques and ELISA in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis

MSM Vidal, LGM Castro, SC Cavalecate… - Revista do Instituto de …, 2003 - SciELO Brasil
Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by several
dematiaceous fungi. The most commonly etiological agent found in Brazil is Fonsecaea …

ITRACONAZOLE IN THE TREAMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI

F QUEIROZ‐TELLES, KS PURIM… - International journal …, 1992 - Wiley Online Library
The efficacy and tolerability of itraconazole in chromoblastomycosis due to Fonsecaea
pedrosoi were evaluated in a non‐comparative open clinical trial in 19 Brazilian patients …

[HTML][HTML] Clinical aspects of previously treated chromoblastomycosis: a case series from Madagascar

FA Sendrasoa, NH Razanakoto… - International Journal of …, 2020 - Elsevier
Objective To describe the clinical aspects of chromoblastomycosis (CBM) presented by
patients who had received incomplete antifungal treatment before consultation. Methods A …

[HTML][HTML] Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis

VMF Gimenes, MDG de Souza, KS Ferreira… - Microbes and …, 2005 - Elsevier
Chromoblastomycosis is a chronic, often debilitating, suppurative, granulomatus mycosis of
the skin and subcutaneous tissues beginning after inoculation trauma. It occurs world-wide …

A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine

XC Shen, XN Dai, ZM Xie, P Li, S Lu, JH Li… - Dermatology and …, 2020 - Springer
Patients with chromoblastomycosis (CBM) usually have a history of local skin damage
related to outdoor activities, mainly manifested as chronic refractory proliferative pathologic …

Reviewing the Etiologic Agents, Microbe‐Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis

LFD Passero, IN Cavallone… - Journal of immunology …, 2021 - Wiley Online Library
Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of
pigmented dematiaceous fungi that cause subcutaneous infections. This disease has been …

Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy

VMF Gimenes, PR Criado, JEC Martins, SR Almeida - Mycopathologia, 2006 - Springer
One of the most characteristic features of the chromoblastomycosis is its unresponsiveness
to treatment. In order to analyzed whether during therapy could be observed a change of …